Pricing Log in Create free account

Carisma Therapeutics Inc. (CARM) vs Propanc Biopharma Inc (PPCB)

Carisma Therapeutics Inc. and Propanc Biopharma Inc are both Biotechnology companies. Propanc Biopharma Inc is the larger, with a market value of $1.7M against $1.5M — 1.1× the size. Carisma Therapeutics Inc. has the higher net margin (14.4% vs 0.00%) and the higher return on invested capital (0.00% vs −125.9%). Across the 12 metrics below, Carisma Therapeutics Inc. leads on 8 and Propanc Biopharma Inc on 4.

Valuation

Metric CARM PPCB Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B n/m 0.02 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.00 0.66
EV/Sales (0.05) n/m 9.02
Earnings yield 0.00% (6,564.98%) (32.88%)
Free cash flow yield 0.00% (2,826.85%) (23.13%)

Profitability

Metric CARM PPCB Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin 19.36% 0.00% 0.00%
Net margin 14.36% 0.00% 0.00%
Free cash flow margin (38.79%) 0.00% 0.00%
Return on equity (134.11%) (169.85%) (51.96%)
Return on assets 33.09% (122.15%) (46.06%)
Return on invested capital 0.00% (125.86%) 0.00%

Growth

Metric CARM PPCB Biotechnology median
Revenue growth (TTM) 170.48% — 6.76%
EPS growth (last fiscal year) 43.68% 95.48% 29.88%
Revenue growth, 5-year CAGR 115.24% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CARM PPCB Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 0.86 2.55 4.97
Net debt to EBITDA 0.30 0.02 1.01

Dividend

Metric CARM PPCB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CARM PPCB Biotechnology median
Market cap 1.52m 1.69m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack